The quantitative structure-activity relationships (QSARs) for polychlorinated biphenyl (PCB) congeners have been determined by comparing the ECQ, values for three in vitro test systems, namely, aryl hydrocarbon hydroxylase (AHH) and ethoxyresorufin O-deethylase (EROD) induction in rat hepatoma H-4-II-E cells and competitive binding avidities to the rat cytosolic receptor protein (using 2,3,7,8-tetrachlorodibenzo-p-dioxin as a radioligand). For several PCB congeners that are in vivo inducers of rat hepatic microsomal AHH, there was a linear correlation between the -log EC.4 values for receptor and&the -log ECso values for AHH (or EROD) induction; moreover, a comparable linear relationship was observed between the -log EC.4 values for AHH and EROD induction. Previous in vivo studies have shown that the most active PCB congeners 3,3',4,4'-tetra-, 3,4,4',5-tetra-, 3,3',4,4',5-penta-, and 3,3',4,4',5,5'-hexachlorobiphenyl, cause many of the biologic and toxic effects reported for the highly toxic halogenated aryl hydrocarbon, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Moreover, the monoortho-substituted homologs of the four coplanar PCBs also elicit comparable in vivo biologic and toxic responses. It was evident from the QSARs for PCBs that there was an excellent correspondence between the in vivo and in vitro potencies of the individual PCB congeners.
Introduction
Pharmacogenetic studies have played an important role in understanding the biologic and toxic effects of carcinogens, drugs and related xenobiotics. Nebert and co-workers have investigated the toxic, carcinogenic, and biologic activities of polynuclear aromatic hydrocarbons (PAHs) in genetically inbred mice strains, and their results have suggested a mechanism of action for these compounds (1) (2) (3) (4) . The activity of 3-methylcholanthrene (3-MC) and several related PAHs as inducers of hepatic and extrahepatic drug-metabolizing enzymes is remarkably dependent on the strain of mice used. Hepatic microsomal aryl hydrocarbon hydroxylase (AHH), a cytochrome P-448-dependent monooxygenase, is readily induced by 3-MC in several strains of mice, typified by the "responsive" C57BL/6J strain; in contrast, 3-MC does not induce AHH in nonresponsive strains, typified by the DBA/2J mice (5, 6) . Moreover, responsive mice are more susceptible than nonresponsive mice to the toxic (inflammation, fetotoxicity, primordial oocyte depletion) and carcinogenic effects of PAHs at organs/tissues in direct contact with the applied PAHs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . The gene complex responsible for mediating the effects of PAHs has been designated the Ah locus which may comprise regulatory, structural, and possibly temporal genes. Extensive studies on genetically inbred responsive and nonresponsive mice (and their backerosses) suggests that the differences in susceptibility are related to the levels of the Ah regulatory gene product, the cytosolic Ah receptor protein. The receptor protein interacts with the PAH ligands and the resultant PAH:receptor ligand complex translocates into the nucleus and presumably initiates the toxic and biologic effects via a process comparable to that proposed for the steroid hormones (1) (2) (3) (4) (5) (6) .
Genetic, biochemical and toxicologic studies also support the role of the Ah receptor protein in mediating the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (14) (15) (16) (17) . For example, competitive binding studies with radiolabeled and unlabeled 2,3,7,8-TCDD and 3-MC confirms that both compounds bind to the same receptor protein (18) . The murine Ah receptor concentrations in C57BL/6J mice vary from 45 to 75 fmole/mg cytosolic protein, whereas this protein is not detected in the cytosol of DBA/2J mice (note: nuclear receptor levels have been detected in this mouse strain) (18) (19) (20) . 2,3,7,8- TCDD induces AHH and causes cleft palate, a wasting syndrome, immunotoxicity and thymic atrophy in responsive C57BL/6J mice; some of these effects are observed in the nonresponsive DBA/2J mice but only at relatively high dose levels (14) (15) (16) (17) (21) (22) (23) . Backcross experiments with DBA/2J and C57BL/6J mice give results consistent with the segregation of the activity of 2,3,7,8-TCDD with the Ah locus (16, 17, 21, 23, 25, 26) . There are marked effects of structure on the activity of polychlorinated dibenzo-p-dioxins (PCDDs); the most active compound, 2,3,7,8-TCDD, is substituted at all four lateral positions. Moreover, the addition of Cl groups or the removal of lateral substituents tends to reduce the activity of the resultant congeners (17, 21, 22, (26) (27) (28) (29) (38) (39) (40) (41) (42) (43) . Although extensive toxicity studies have not been reported for all three congeners, it is apparent that one or more of these PCBs elicit the following toxic effects; a wasting syndrome, thymic atrophy, hepatic damage, reproductive toxicity, differential effects on genetically inbred C57BL/6J and DBA/2J mice, porphyria, immunotoxicity, and dermal toxicity (42, (44) (45) (46) (47) (48) (49) (50) (51) .
Studies in our laboratory have shown that all the mono-ortho analogs of the 3,3',4,4'-tetra-, 3,4,4',5-tetra-, 3,3',4,4',5-penta-and 3,3,4,4,5,5'-hexachlorobiphenyls also induce hepatic microsomal AHH and EROD in male Wistar rats and C57BL/6J mice. However, in contrast to the highly toxic coplanar PCBs, these compounds resemble phenobarbitone (PB) plus 3-MC (coadministered) as inducers of hepatic microsomal drug-metabolizing enzymes (42, 52, 53) . Despite this apparent bifunctional or "mixed-type" enzyme induction activity, there is evidence in the literature that many of these compounds also cause toxic effects similar to those observed after treatment with 2,3,7,8-TCDD. For example: 2,3',4,4',5-penta-, 2,3,3',4,4'-penta-, 2,3,3',4,4',5-hexa-, and 2,3,3' ,4,4' ,5'-hexachlorobiphenyl cause thymic atrophy in rats (50 (57) and the AHH and EROD induction potencies of these compounds in rat hepatoma H-4-II-E cells in culture (34) . The former assay measures the important interaction between the toxin or ligand and the receptor protein, whereas the induction assay measures one of the biologic consequences (i. e., the induction of cytochrome P-448-dependent monooxygenases of this initial interaction). Dose-response studies are also readily determined by using in vitro assays, and the pharmacokinetic and metabolic factors which play a role in in vivo studies are minimized. The QSAR for the binding avidities of PCBs to the cytosolic receptor protein have been reported by using the sucrose density gradient assay system (57) . Figure  1 
PBBs
In vivo studies with purified PBB congeners indicate that their biologic and toxic properties and the effects of structure on activity are comparable to those observed for the PCBs. The coplanar PBBs substituted in both para and two or more meta positions are highly toxic (29, 42, (58) (59) (60) (61) , induce microsomal AHH and the associated cytochrome P450 isozymes in rats (42, 60, 62) , and elicit differential biologic and toxic effects in genetically inbred C57BL/6J and DBA/2J mice (50) . Moreover, many of the monoortho analogs of the coplanar PBBs are mixed-type inducers (i.e., inducers of cytochromes P-450a-P-450e) (42, 60, (62) (63) (64) (65) and also cause some of the toxic effects observed for the coplanar congeners (42, (63) (64) (65) (66) Figure 7 . The in vivo activity of these compounds as inducers of microsomal AHH, EROD and DMAP N-demethylase were remarkably dependent on the structure of the 4'-substituent. The 4'-iodo-2,3,4,5-tetrachlorobiphenyl was the most potent inducer of AHH and EROD; however, the 4'-bromo-, 4'-chloro-, 4'-trifluoromethyl, 4'-nitro-,4'-cyano-, 4'-tertbutyl-, 4'-isopropyl-, 4'-fluoro-, 4'-phenyl-, 2,3,4,5-tetrachlorobiphenyls also significantly induced both cytochrome P-448-dependent monooxygenases. There were also substituent effects on the activity of these compounds as inducers of DMAP N-demethylase; the chloro-, bromo-, fluoro-, nitro-, and cyano-substituted PCBs were inducers, whereas the 4'-trifluoromethyl-, 4'-iodo-, 4'-isopropyl-, and 4'-tert-butyl-2,3,4,5-tetrachlorobiphenyls were inactive. A second group of 4'-substituted 2,3,4,5-tetrachlorobiphenyls, namely the 4'-acetyl-, 4'-methyl-, and 4'-hydroxy-2,3,4,5-tetrachlorobiphenyls and 2,3,4,5-tetrachlorobiphenyl do not induce any of the cytochrome P-450-dependent monooxygenases. The rationale for the effects of substituents on the in vivo microsomal monooxygenase enzyme-inducing activities ofthe substituted PCBs is not apparent: One possible explanation for these differences in activity may be associated with hepatic residue levels of these compounds. The results summarized in Table 2 clearly show that the most active AHH and EROD inducers persist in the liver at concentrations which range from 36.34 to 17.04 ppm. However, 4'-isopropyl-, 4'-tert-butyl-and 4'-phenyl-2,3,4,5-tetrachlorobiphenyl also significantly induce AHH and EROD and their hepatic levels are in the range of 1 to 4 ppm. Although residue levels may play a role in the in vivo potencies of the 4'-substituted-2,3,4,5-tetrachlorobiphenyls, it is probable that many factors (e. g., metabolic rates) including the substituent properties are important determinants for the in vivo activities.
The quantitative effects of the 4'-substituents on activity are more readily assessed using the in vitro bioassays (73) since these procedures minimiize the importance of metabolic and pharmacokinetic factors. 6. bResidue levels of this compound in adipose tissue were 325.07 ± 188.36 (n = 4). CND = non-detectable. From inspection of the results of competitive binding experiments (Table 3) , it is apparent that some substituent groups enhance the binding of 4'-substituted-2,3,4,5-tetrachlorobiphenyls relative to that of 2,3,4,4',5-pentachlorobiphenyl (i. e., 4'-chloro-2,3,4,5-tetrachlorobiphenyl), while others diminished it. The relative competitive potency of the 4'-substituted 2,3,4,5-tetrachlorobiphenyls followed the order CF3> CH(CH3)2 > I > Br > CH2CH3> Cl for the most effective ligands. In fact, 4'-trifluoromethyl-2,3,4,5-tetrachlorobiphenyl (i. e., 4'-CF3 derivative) competed with [3H]-2,3,7,8-TCDD for the specific binding sites almost as effectively as 3,3',4,4',5-pentachlorobiphenyl, the most potent competitor of all the PCBs previously tested. The finding that both the 4'-ethyl and 4'-isopropyl compounds were active competitors for the receptor indicates that halogen substitution in both phenyl rings is not a requirement for binding.
Since the ability to bind effectively to the cytosolic receptor is either enhanced or reduced by various substituent groups on the tetrachlorobiphenyl backbone, the variation in biological activity must be dependent on the properties inherent in the substituents. Quantitative analysis of substituent structure-activity effects can be used to study the intermolecular interactions between ligands and their receptors (74) (75) (76) (77) . In general, drug-receptor interactions involve such forces as hydrophobic bonding, hydrogen bonding, van der Waals energy, electrostatic energy, valence-bond energy, and repulsion or strain energies of the bonds (77) . The strength of the interaction depends upon the use of these various energies, which for a series of substituted congeners, can be approximated by the use of free-energyrelated physiochemical substituent parameters (74) (75) (76) (77) (78) . For the present series of 4'-substituted tetrachlorobiphenyls, the relationships between various substituent parameters and receptor binding constants were examined by means of multiparameter regression analysis.
For each substituent group, a hydrophobic parameter ,Tr, an electronic parameter a, and a hydrogen-bonding accepting parameter HB were determined. The hydrogen-bonding parameter HB is an indicator variable that takes a value of unity for substituents which are hydrogen acceptors but a value of zero for nonhydrogenbonders. For the electronic effect of 4'-substituents, upara (Hammett constant) was used. (Table 3) .
number of compounds is given by n, s is the standard deviation, r is the correlation coefficient, and F is the value of the F-ratio. with n = 12, s = 0.18, r = 0.978, F = 65.90 (a < 0.01%). Although the quality of the correlation is much improved, the inferences drawn from the correlation are not significantly changed. The 4'-n-butyl, 4'-tert-butyl and 4'-phenyl compounds were not included in these correlations. Their log(1/EC.) values were much lower than those predicted by the two correlation equations. The van der Waals volumes of these three substituents were among the highest, being 41.8 cm3/mole for the n-butyl/ and tert-butyl groups and 45.8 cm3/mole for phenyl. The value for other substituents used here was less than 35 cm3/ mole (i.e., 34.12 cm3/mole for isopropyl and 33.23 cm3/ mole for N-acetylamino). Although the use of various types of steric parameters did not produce meaningful correlations, there seems to be a certain limiting size in the receptor binding site(s) to accommodate the biphenyl derivatives.
The correlation (developed in the above equations) means that both increasing substituent electron with- than receptor binding to the structural variations of the 4'-substituents. The AHH induction is also dependent parabolically with the maximum width of the substituent X, the optimum width being 1.4, 'Which is close to the value of the NO2and CF3 substituents. This suggests that the interaction of the ligand:receptor protein complex with the nuclear receptor site is dependent on the conformation of this complex which in turn is governed by the size of the 4'-X substituent.
The importance of the size of the substituents is evident in the receptor binding affinities of a series of halogenated biphenyls which contain two vicinal meta and Para (4-) substituents in one of the phenyl rings. 
